#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary haemorrhagic telangiectasia Idiopathic intracranial hypertension Amyotrophic lateral sclerosis gene carrier Retinoblastoma Haemolytic uraemic syndrome Mitochondrial myopathy Rett syndrome Restless legs syndrome Von Willebrand's disease Muscular dystrophy Erdheim-Chester disease Acute myeloid leukaemia (in remission) Diabetes insipidus Endometrial cancer Crigler-Najjar syndrome More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome – Basic Information Synovial sarcoma Indolent systemic mastocytosis – Life with Disease Langerhans’ cell histiocytosis – Diagnostics SAPHO syndrome – Life with Disease Idiopathic pulmonary fibrosis – Life with Disease Rosai-Dorfman syndrome – Basic Information Osteosarcoma – Trials in Disease Synovial sarcoma – Treatment Advanced systemic mastocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-Threonine Bleomycin Sulfate Pemetrexed Diacid Monohydrate Temsirolimus Lurasidone Camizestrant Petrelintide Tipranavir Ribonucleic Acid K30 Aldesleukin Befiradol (18F) Febuxostat Egl-001 GSKVX000000034794 Dmd06-Mab Argipressin Tolebrutinib Glutenin Cevostamab Tacrolimus Monohydrate More therapies…

    Learn about Your Condition

    Type 1 diabetes mellitus Incontinence Vascular malformation Acute on chronic liver failure Mechanical ventilation Asplenia Infectious pleural effusion Diabetes insipidus Pulmonary sarcoidosis Acarodermatitis Autoimmune uveitis Hepatobiliary cancer Renal failure Rhabdoid tumour Status epilepticus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Praxisklinik Urologie Rhein Ruhr

Praxisklinik Urologie Rhein Ruhr

Schulstrasse 11, Mülheim an der Ruhr, 45468, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Durvalumab
    • Infliximab
    • Mycophenolate Mofetil
    Austria Belgium France Germany The Netherlands Poland +1

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!